Numerous studies have identified stem-like cells, termed cancer stem cells (CSCs), in breast tumors and established cell lines. It has been hypothesized that CSCs are responsible for breast cancer formation, progression and recurrence; therefore, a deeper understanding of the signaling pathways regulating CSC survival will benefit development of novel therapeutic strategies. Notch signaling, which is dysregulated in breast cancer and has been implicated in mammary stem cell self-renewal, and can be effectively blocked by gamma-secretase inhibitors (GSIs). While GSIs are currently in clinical trials for breast cancer, it is not fully understood how these compounds will affect CSCs or if CSCs from different breast cancer phenotypes will be di...
Purpose: Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer is driven by cells p...
Trastuzumab targets the HER2 receptor on breast cancer cells to attenuate HER2-driven tumor growth. ...
The Notch signaling pathway regulates cell proliferation, cytodifferentiation and cell fate decision...
Developmental pathways such as Notch play a pivotal role in tissue-specific stem cell self-renewal a...
Abstract Introduction Notch signaling has been implic...
Notch signaling is associated with activation of either oncogenic or tumor suppressor activities. Th...
The Notch signalling pathway is a highly conserved developmental signalling pathway, with vital role...
Breast cancer is the most common cancer and the most frequent cause of cancer related mortality amon...
Objective. Notch signaling pathway is a vital parameter of the mammalian vascular system. In this re...
The mammary gland is a highly regenerative organ that can undergo multiple cycles of proliferation, ...
INTRODUCTION: Dysregulated NOTCH receptor activity has been implicated in breast cancer but the mech...
Notch-1 is a cell fate regulatory protein and a potent breast oncogene. Notch-1 and its ligand Jagge...
The cancer stem cell (CSC) theory states that only some cells from a heterogeneous tumor are capable...
A dissertation submitted to the Faculty of Health Sciences, School of Clinical Medicine Department ...
[Abstract] A new theory about the development of solid tumours is emerging from the idea that solid ...
Purpose: Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer is driven by cells p...
Trastuzumab targets the HER2 receptor on breast cancer cells to attenuate HER2-driven tumor growth. ...
The Notch signaling pathway regulates cell proliferation, cytodifferentiation and cell fate decision...
Developmental pathways such as Notch play a pivotal role in tissue-specific stem cell self-renewal a...
Abstract Introduction Notch signaling has been implic...
Notch signaling is associated with activation of either oncogenic or tumor suppressor activities. Th...
The Notch signalling pathway is a highly conserved developmental signalling pathway, with vital role...
Breast cancer is the most common cancer and the most frequent cause of cancer related mortality amon...
Objective. Notch signaling pathway is a vital parameter of the mammalian vascular system. In this re...
The mammary gland is a highly regenerative organ that can undergo multiple cycles of proliferation, ...
INTRODUCTION: Dysregulated NOTCH receptor activity has been implicated in breast cancer but the mech...
Notch-1 is a cell fate regulatory protein and a potent breast oncogene. Notch-1 and its ligand Jagge...
The cancer stem cell (CSC) theory states that only some cells from a heterogeneous tumor are capable...
A dissertation submitted to the Faculty of Health Sciences, School of Clinical Medicine Department ...
[Abstract] A new theory about the development of solid tumours is emerging from the idea that solid ...
Purpose: Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer is driven by cells p...
Trastuzumab targets the HER2 receptor on breast cancer cells to attenuate HER2-driven tumor growth. ...
The Notch signaling pathway regulates cell proliferation, cytodifferentiation and cell fate decision...